GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Change In Payables And Accrued Expense

Stella Diagnostics (Stella Diagnostics) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Change In Payables And Accrued Expense?

Stella Diagnostics's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was $0.00 Mil. It means Stella Diagnostics's Accounts Payable & Accrued Expense stayed the same from Sep. 2022 to Sep. 2023 .

Stella Diagnostics's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was $0.00 Mil. It means Stella Diagnostics's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


Stella Diagnostics Change In Payables And Accrued Expense Historical Data

The historical data trend for Stella Diagnostics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Change In Payables And Accrued Expense Chart

Stella Diagnostics Annual Data
Trend
Change In Payables And Accrued Expense

Stella Diagnostics Quarterly Data
Sep22 Sep23
Change In Payables And Accrued Expense - -

Stella Diagnostics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stella Diagnostics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Diagnostics (Stella Diagnostics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104
Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.

Stella Diagnostics (Stella Diagnostics) Headlines

From GuruFocus